HPQ — HP Inc.

The tape is decisively bullish: a +8.4% day, +21.2% month, +87.4% six months, RSI 71.1. The trigger was the Q3 FY26 report (filed 2026-08-27): record revenue of $15.677B, +12.5% YoY, non-GAAP EPS $0.83 (including $0.11 of one-time tariff refunds), FY26 non-GAAP EPS guidance raised to $3.19–$3.29, and FCF guidance lifted to $3.0–$3.2B. Management's AI-PC story (≈46% of shipments, commercial revenue +22% YoY) is what the market is paying for. Notably, the fundamental analyst community is NOT endorsing the move — consensus rating is Hold, the consensus target is $25.75, and even the most recent average target is $29.60, so the rally is momentum/narrative-driven rather than valuation-driven.

Revenue growth is genuinely accelerating on a YoY basis: +2.4% (Q1 FY25), +3.3% (Q2 FY25), +3.1% (Q3 FY25), +4.2% (Q4 FY25), +6.9% (Q1 FY26), +9.0% (Q2 FY26), +12.5% (Q3 FY26, $15.677B). That is the single cleanest positive in the dataset. But the quality of that growth is poor. Gross profit in Q3 FY26 was $2.945B versus $2.851B a year earlier — only +3.3% on +12.5% revenue — and gross margin has compressed from 21.6% (Q4 FY23) to 18.8% (Q3 FY26), a ~280bp structural decline. Operating margin tells the same story: ~7.0–7.4% through FY23/FY24, 5.14% in Q3 FY25, 4.25% in Q2 FY26, recovering to 5.69% in Q3 FY26. Operating income is choppy and still below FY24 levels ($892M in Q3 FY26 vs $940M in Q3 FY24 on 16% less revenue). GAAP diluted EPS actually FELL YoY in Q3 FY26 ($0.71 vs $0.80). Bottom line: this is a price/mix-driven revenue inflection layered on top of a multi-year margin compression and shrinking unit volumes — not an earnings inflection yet. Treat the accelerating top line as real but fragile, not as operating leverage.

Expensive relative to its own history. As of 2026-09-13, HPQ's TTM P/E was 13.39x versus a 5-year average of 9.17x — a ~46% premium to its own norm. P/S is 0.548 versus a 5-year average of 0.53, roughly in line. EV/EBITDA is 10.4x and price/cash flow 7.9x. The forward math is more forgiving: FY27 consensus EPS of $3.257 implies ~10.9x forward, and the FY26 guide midpoint of $3.24 implies essentially the same. So the stock is not absurd on forward numbers — it is the re-rating that is the issue. The multiple expanded from ~9x to ~13.4x while TTM GAAP EPS went from $2.65-ish to $2.62 — i.e., investors paid up before the earnings showed up. Dividend yield of 3.7% and trailing FCF yield of ~12% ($3.88B trailing FCF on a $32.45B market cap) are the genuine supports underneath.

The market is pricing in a recovery that has not yet appeared in GAAP earnings. The stock has re-rated ~46% above its 5-year average P/E while trailing GAAP EPS is flat-to-down and gross margin is compressing — that is textbook 'multiple paid in advance.' To justify $35.48, you need FY27 EPS of $3.257 at ~10.9x, and critically, you need Q4 FY26 (late Nov 2026) and the FY27 guide to show AI-PC mix actually converting into gross margin rather than just ASP inflation. If memory costs keep rising and gross margin stays near 19%, the multiple compresses back toward 9–10x, which on $3.26 EPS is $29–$33. So the earnings are not 'pricing in a turnaround' — the price is pricing in a margin recovery that hasn't started. The skew is unfavourable: limited upside to the multiple, real downside if the Q4 print is merely in line.

Parabolic and overbought as of 2026-09-13. RSI-14 was 71.1; price was 15.0% above the SMA20, 26.5% above the SMA50 and 53.8% above the SMA200. Returns: +8.7% 1wk, +21.2% 1mo, +40.6% 3mo, +87.4% 6mo. That implies SMA20 ≈ $30.85, SMA50 ≈ $28.05, SMA200 ≈ $23.07. There is essentially no nearby support — a mean-reversion move to the 20-day alone is -13%, and to the 50-day is -21%. Entry timing implication: buying into this strength offers very poor risk/reward; the rational play is to wait for either a pullback into the $29–$32 zone or a multi-week sideways consolidation that lets the moving averages catch up. Momentum names like this can keep running, but the asymmetry here is bad.

• AI PC / Windows 11 enterprise refresh cycle: commercial Personal Systems revenue +22% YoY with AI PCs at ~46% of shipments is the primary tailwind and the entire basis of the re-rating.
• Memory and component cost inflation: management has repeatedly flagged rising DRAM/NAND costs; passing these through via price hikes protects margin but risks accelerating the already-visible volume decline (-16% YoY total units).
• Tariff and trade policy lumpiness: Q3 FY26 non-GAAP EPS got a one-time $0.11 boost from tariff refunds, which flatters the year and makes YoY comparisons noisy.
• Soft PC unit demand: growth is entirely average-selling-price and mix driven; consumer and SMB hardware demand remains rate- and macro-sensitive.
• Structural printing decline: Printing revenue -2% YoY with supplies -3%, eroding the highest-margin annuity that funds the dividend and buyback.
• Rate sensitivity: beta of 1.205 and a re-rated multiple mean any rise in long yields disproportionately pressures the valuation case.

• Q4 FY26 earnings in late November 2026 — the first real test of whether AI-PC mix converts into gross margin, and whether the FY27 EPS guide supports the $3.257 consensus.
• Memory/DRAM-NAND pricing trajectory into H1 FY27 — easing costs would unlock the margin recovery the stock is already paying for; further spikes would force a guide-down.
• AI PC penetration crossing 50%+ of shipments and a broadening enterprise Windows 11 replacement wave.
• Permanent CEO appointment — Bruce Broussard remains Interim CEO; a permanent hire could reset strategy and capital allocation.
• Continued aggressive buybacks (the source of the negative equity) supporting EPS even with flat net income.

• Valuation and positioning risk: 13.4x TTM P/E vs. a 9.17x 5-year average, RSI 71.1, and a share price ~38% above the $25.75 consensus target — the stock is discounting results that analysts do not forecast.
• Gross margin compression: 18.8% in Q3 FY26 vs. 21.6% in Q4 FY23; revenue grew 12.5% YoY but gross profit grew only 3.3%, so incremental revenue is arriving at almost no incremental gross profit.
• Unit volume erosion: total units -16% YoY, meaning the entire growth story rests on price and mix, which is the most reversible form of growth if demand weakens.
• Printing annuity decay: supplies -3% YoY in the highest-margin segment is a slow structural bleed that caps long-term margin recovery.
• Balance-sheet optics: stockholders' equity of -$92M, current ratio 0.788 and quick ratio 0.484 leave a thin liquidity cushion, even though FCF generation is genuinely strong.
• Leadership and earnings-quality noise: an interim CEO plus one-off tariff refunds embedded in non-GAAP EPS make the quality of the beat harder to underwrite.

Not a buy at $35.48. HP is a fair-quality, genuinely cash-generative hardware business (25% ROIC, ~12% trailing FCF yield, 3.7% dividend) that has been re-rated 87% in six months on an AI-PC narrative while its actual GAAP earnings went sideways and gross margin compressed ~280bp over three years. The forward P/E of ~10.9x on $3.26 of FY27 EPS is not crazy on its own, but the stock already sits well above every published analyst target, the technicals are parabolic, and unit volumes are falling 16%. This is a case where the price got ahead of the earnings; the right posture is to wait for a pullback into the high-$20s/low-$30s where the FCF yield and dividend actually compensate you for the structural printing and margin risks.

Blended two approaches as of 2026-09-13: 60% weight to a forward P/E of 10.5x on FY27 consensus EPS of $3.257 (= $34.20) — a premium to HP's 5-year average of 9.17x to credit the AI-PC/Windows 11 refresh, but well below the current 13.39x TTM — and 40% weight to an 11% target FCF yield on the midpoint of management's FY26 FCF guidance of $3.1B, which on ~914M shares is $3.39/share and values the equity at $30.82. The blend is $32.85, roughly 7% below the 2026-09-13 price of $35.48 and above the $25.75 consensus target, reflecting a business that is cash-rich but margin-constrained and priced ahead of its earnings.